Lithium Orotate

Ecological and epidemiological data suggest low-dose lithium may support mood and longevity, but supplement-dose clinical trials are very limited. Not interchangeable with prescription lithium.

A rough internal score reflecting quantity, quality, and consistency of human evidence. Not a clinical recommendation.

Ecological studies associate higher lithium levels in drinking water with lower suicide rates, reduced dementia incidence, and greater longevity. Lithium promotes BDNF expression and inhibits GSK-3beta, relevant to neuroprotection. However, clinical trials at supplement doses (5-20 mg elemental lithium) are nearly nonexistent.

• Epidemiological association with lower suicide rates and dementia risk
• Neuroprotective via GSK-3beta inhibition and BDNF promotion
• May support mood stability at low doses

Supplement doses typically provide 5-20 mg elemental lithium daily, far below therapeutic psychiatric doses (900-1200 mg lithium carbonate).

• Potential thyroid suppression with chronic use
• GI discomfort
• Mild tremor
• Kidney impact with long-term use (even at low doses, monitoring advised)

Even low-dose lithium can affect thyroid and kidney function with long-term use. Should not be combined with prescription lithium without medical supervision. Not appropriate for self-treating bipolar disorder.

Claims that orotate salt provides superior brain penetration are unverified in humans. Epidemiological associations with drinking water lithium do not prove supplementation benefits.

• Mood35
• Longevity30
• Memory25